N

Nyxoah
NYXH

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€252.63M
EV
€211.68M
Shares Outstanding
37.43M
Beta
0.67

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€12.40
P/E 2025E
-
P/Revenue 2025E
18.80x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Nyxoah S.A.

gainify

N

Nyxoah S.A.

NYXH

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation ...

Sector

Industry

CEO

Taelman, Olivier

Employees

184

IPO Date

Headquarters

Rue Edouard Belin 12, Mont-Saint-Guibert, Walloon Brabant, 1435, Belgium

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.